Literature DB >> 11600813

[The search for therapeutic gain in radiation oncology].

F Wenz1, U Tiefenbacher, F Willeke, K J Weber.   

Abstract

The Search for Therapeutic Gain in Radiation Oncology Novel strategies in radiation oncology aim at increasing the therapeutic gain, i.e., to decrease side effects while maintaining cure rates, or to increase cure rates at the same level of complications. Over the years, physical and biological strategies have been developed to achieve this goal. The physical development led to the possibility of precise, computer-controlled beam application by using modern imaging techniques and three-dimensional treatment planning. Improved patient immobilization methods allow minimal safety distances, resulting in steep dose gradients when used together with isocentric multi-field techniques. These predominantly stereotactic irradiation techniques yield therapeutic gain towards the tumor surrounding normal tissue. A critical issue that determines the tolerance of radiation therapy are structures at risk within the target volume. Fractionation is a reliable method to exploit the differential potential for recovery of radiation-induced DNA damage in normal tissues. Radiogenetic strategies aim at the sensibilization of tumor cells by targeting specific characteristics like mutations of p53. The reverse idea, gene-therapeutic radioprotection of normal tissue, is under investigation. Copyright 2001 S. Karger GmbH, Freiburg

Entities:  

Mesh:

Year:  2001        PMID: 11600813     DOI: 10.1159/000055187

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  8 in total

1.  [Image-guided radiation therapy. Paradigm change in radiation therapy].

Authors:  F Wenz; C Belka; M Reiser; S O Schönberg
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

2.  Dentofacial parameters explaining variability in retroclination of the maxillary central incisors.

Authors:  Bernd G Lapatki; Andreas Klatt; Jürgen Schulte-Mönting; Irmtrud E Jonas
Journal:  J Orofac Orthop       Date:  2007-03       Impact factor: 1.938

Review 3.  Radioprotection of normal tissue cells.

Authors:  Patrick Maier; Frederik Wenz; Carsten Herskind
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

4.  Cellular Uptake of Gold Nanoparticles and Their Behavior as Labels for Localization Microscopy.

Authors:  Felipe Moser; Georg Hildenbrand; Patrick Müller; Alexander Al Saroori; Abin Biswas; Margund Bach; Frederik Wenz; Christoph Cremer; Nina Burger; Marlon R Veldwijk; Michael Hausmann
Journal:  Biophys J       Date:  2016-02-23       Impact factor: 4.033

Review 5.  Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization.

Authors:  Patrick Maier; Linda Hartmann; Frederik Wenz; Carsten Herskind
Journal:  Int J Mol Sci       Date:  2016-01-14       Impact factor: 5.923

6.  Challenges for Super-Resolution Localization Microscopy and Biomolecular Fluorescent Nano-Probing in Cancer Research.

Authors:  Michael Hausmann; Nataša Ilić; Götz Pilarczyk; Jin-Ho Lee; Abiramy Logeswaran; Aurora Paola Borroni; Matthias Krufczik; Franziska Theda; Nadine Waltrich; Felix Bestvater; Georg Hildenbrand; Christoph Cremer; Michael Blank
Journal:  Int J Mol Sci       Date:  2017-09-28       Impact factor: 5.923

7.  Dose enhancement effects of gold nanoparticles specifically targeting RNA in breast cancer cells.

Authors:  Georg Hildenbrand; Philipp Metzler; Götz Pilarczyk; Vladimir Bobu; Wilhelm Kriz; Hiltraud Hosser; Jens Fleckenstein; Matthias Krufczik; Felix Bestvater; Frederik Wenz; Michael Hausmann
Journal:  PLoS One       Date:  2018-01-18       Impact factor: 3.240

8.  Challenges and Contradictions of Metal Nano-Particle Applications for Radio-Sensitivity Enhancement in Cancer Therapy.

Authors:  Eva Pagáčová; Lenka Štefančíková; Franz Schmidt-Kaler; Georg Hildenbrand; Tomáš Vičar; Daniel Depeš; Jin-Ho Lee; Felix Bestvater; Sandrine Lacombe; Erika Porcel; Stéphane Roux; Frederik Wenz; Olga Kopečná; Iva Falková; Michael Hausmann; Martin Falk
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.